COVID-19 updates - Get the latest information about Coronavirus and Iowa Heart Center

Trial to Assess Chelation Therapy 2 (TACT2)

Purpose of Study

To assess if chelation treatments in the vein and oral vitamins and minerals by mouth lower the risk of new heart problems, including another heart attack, chest pains, or heart surgery to open blood vessels, in patients who have diabetes and have had a heart attack.

Trial Status

Enrolling

Eligibility Criteria

50 years old or greater, history of diabetes, and history of myocardial infarction.

Duration of Participation

Approximately 5 years

Contact Name: Donna Prouty, RN

Contact Phone: 515-633-3848

Contact Email: dprouty@iowaheart.com